510(k) K193103
K193103 is an FDA 510(k) premarket notification submitted by Perkinelmer, Inc. for the device "NeoBase 2 Non-derivatized MSMS Kit". The FDA issued a decision of Substantially Equivalent on Feb 7, 2020. The device falls under product code NQL (System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry), a Class II device regulated under 21 CFR 862.1055. Perkinelmer, Inc. has 16 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 7, 2020
- Date Received
- Nov 8, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry
- Device Class
- Class II
- Regulation Number
- 862.1055
- Review Panel
- CH
- Submission Type
- 510(k)
Amino acids, free carnitines and acylcarnitines test system is intended for the measurement and evaluation of amino acid, free carnitine and acylcarnitine concentrations from newborn whole blood filter paper samples. The quantitative analysis of the amino acids, free carnitines and acylcarnitines and their relationship with each other is intended to provide analyte concentration profiles that should aid in identifying elevated levels of these metabolites for screening newborns for one or more of several metabolic disorders.
Need the full FDA record for Perkinelmer, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.